3-aminoisobutyric acid has been researched along with Hypertension in 2 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, H; Chen, L; Chen, S; Chen, X; Du, J; Gao, D; Jin, Y; OuYang, Y; Tian, Z; Yang, Z; Zhao, X; Zheng, X; Zhou, L | 1 |
Hou, XW; Li, X; Wang, YB; Yin, B | 1 |
2 other study(ies) available for 3-aminoisobutyric acid and Hypertension
Article | Year |
---|---|
β-Aminoisobutyric acid supplementation attenuated salt-sensitive hypertension in Dahl salt-sensitive rats through prevention of insufficient fumarase.
Topics: Aminoisobutyric Acids; Animals; Blood Pressure; Dietary Supplements; Fumarate Hydratase; Hypertension; Rats; Rats, Inbred Dahl | 2022 |
β‑aminoisobutyric acid ameliorates hypertensive vascular remodeling via activating the AMPK/SIRT1 pathway in VSMCs.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Hypertension; Kelch-Like ECH-Associated Protein 1; Muscle, Smooth, Vascular; NF-E2-Related Factor 2; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sirtuin 1; Vascular Remodeling | 2022 |